# Bruce Crawford

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/bruce-crawford/

## Facts

| Field | Value |
| --- | --- |
| Citations | 3,768 |
| Field | Health Systems, Economic Evaluations, Quality of Life |
| h-index | 29 |
| i10-index | 49 |
| OpenAlex ID | https://openalex.org/A5078326675 |
| ORCID iD | 0000-0001-9109-728X |
| Works | 132 |

## Researcher papers

- [PRO development: rigorous qualitative research as the crucial foundation](https://scholariq.org/papers/pro-development-rigorous-qualitative-research-as-the-crucial-foundation/)
- [Bayesian Meta-Analysis of Multiple Treatment Comparisons: An Introduction to Mixed Treatment Comparisons](https://scholariq.org/papers/bayesian-meta-analysis-of-multiple-treatment-comparisons-an-introduction-to/)
- [Mapping to Estimate Health-State Utility from Non–Preference-Based Outcome Measures: An ISPOR Good Practices for Outcomes Research Task Force Report](https://scholariq.org/papers/mapping-to-estimate-health-state-utility-from-non-preference-based-outcome/)
- [Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: Sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial](https://scholariq.org/papers/clinical-improvement-as-reflected-in-measures-of-function-and-health-related/)
- [Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models: An ISPOR Good Practices for Outcomes Research Task Force Report](https://scholariq.org/papers/identification-review-and-use-of-health-state-utilities-in-cost-effectiveness/)
- [An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial](https://scholariq.org/papers/an-index-of-the-three-core-data-set-patient-questionnaire-measures-distinguishes/)
- [Patient Self-Reports in Pharmacoeconomic Studies](https://scholariq.org/papers/patient-self-reports-in-pharmacoeconomic-studies/)
- [Function and health-related quality of life: Results from a randomized controlled trial of leflunomide versus methotrexate or placebo in patients with active rheumatoid arthritis](https://scholariq.org/papers/function-and-health-related-quality-of-life-results-from-a-randomized-controlled/)
- [Development of the ASK-20 Adherence Barrier Survey](https://scholariq.org/papers/development-of-the-ask-20-adherence-barrier-survey/)
- [Development and validation of a cough and sputum assessment questionnaire](https://scholariq.org/papers/development-and-validation-of-a-cough-and-sputum-assessment-questionnaire/)
- [Family caregiver burden of patients with osteoporotic fracture in Japan](https://scholariq.org/papers/family-caregiver-burden-of-patients-with-osteoporotic-fracture-in-japan/)

## Researcher topics

- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.